Teachers Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $99M | Buy |
732,199
+421,595
| +136% | +$57M | 0.12% | 170 |
|
|
2018
Q4 | $30.2M | Sell |
310,604
-119,804
| -28% | -$11.7M | 0.04% | 439 |
|
|
2018
Q3 | $59.8M | Sell |
430,408
-2,766
| -0.6% | -$385K | 0.07% | 302 |
|
|
2018
Q2 | $53.8M | Sell |
433,174
-420,726
| -49% | -$52.2M | 0.07% | 335 |
|
|
2018
Q1 | $95.2M | Buy |
853,900
+109,793
| +15% | +$12.2M | 0.12% | 184 |
|
|
2017
Q4 | $89M | Buy |
744,107
+126,250
| +20% | +$15.1M | 0.11% | 197 |
|
|
2017
Q3 | $86.7M | Sell |
617,857
-378,073
| -38% | -$53M | 0.12% | 200 |
|
|
2017
Q2 | $121M | Buy |
995,930
+573,663
| +136% | +$69.8M | 0.17% | 131 |
|
|
2017
Q1 | $51.2M | Buy |
422,267
+12,179
| +3% | +$1.48M | 0.07% | 329 |
|
|
2016
Q4 | $50.2M | Sell |
410,088
-186,795
| -31% | -$22.9M | 0.08% | 301 |
|
|
2016
Q3 | $73.1M | Sell |
596,883
-156,950
| -21% | -$19.2M | 0.12% | 197 |
|
|
2016
Q2 | $88M | Buy |
753,833
+214,483
| +40% | +$25M | 0.15% | 157 |
|
|
2016
Q1 | $75.1M | Buy |
539,350
+47,070
| +10% | +$6.55M | 0.14% | 169 |
|
|
2015
Q4 | $93.9M | Buy |
492,280
+38,395
| +8% | +$7.32M | 0.18% | 116 |
|
|
2015
Q3 | $71M | Sell |
453,885
-272,862
| -38% | -$42.7M | 0.14% | 162 |
|
|
2015
Q2 | $131M | Buy |
726,747
+205,429
| +39% | +$37.1M | 0.24% | 68 |
|
|
2015
Q1 | $90.3M | Buy |
521,318
+76,426
| +17% | +$13.2M | 0.17% | 138 |
|
|
2014
Q4 | $82.3M | Buy |
444,892
+34,378
| +8% | +$6.36M | 0.16% | 148 |
|
|
2014
Q3 | $68.1M | Sell |
410,514
-44,191
| -10% | -$7.33M | 0.14% | 177 |
|
|
2014
Q2 | $71M | Sell |
454,705
-55,723
| -11% | -$8.71M | 0.15% | 160 |
|
|
2014
Q1 | $77.7M | Sell |
510,428
-268,316
| -34% | -$40.8M | 0.17% | 134 |
|
|
2013
Q4 | $104M | Sell |
778,744
-47,652
| -6% | -$6.34M | 0.23% | 80 |
|
|
2013
Q3 | $96M | Buy |
826,396
+183,717
| +29% | +$21.3M | 0.24% | 77 |
|
|
2013
Q2 | $59.3M | Buy |
+642,679
| New | +$59.3M | 0.16% | 141 |
|